Onyx Biotec Limited — Updates

Onyx Biotec has submitted a detailed public statement to the stock exchange. This disclosure is made in compliance with SEBI regulations, specifically regarding substantial acquisitions or takeovers. The statement is intended for the attention of the company's public shareholders.

For investors, this development signals that a significant corporate action is likely in the pipeline. The detailed statement will provide clarity on the nature of the transaction, such as whether it is a merger, acquisition, or a change in control of the company. It is a crucial document for shareholders to review to understand the potential impact on their investment.

Shareholders should wait for the full details of the statement to be made public. The market will react based on the content of the disclosure, which will outline the terms and conditions of the proposed corporate action. Investors are advised to stay informed as more information becomes available.